Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group (Q78160767)
Jump to navigation
Jump to search
scientific article published on 01 January 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group |
scientific article published on 01 January 1999 |
Statements
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study Group (English)
P E Goss
E P Winer
L H Schwartz
1 January 1999